Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10,706 GBX | -0.34% | +2.69% | +1.02% |
Mar. 27 | AstraZeneca CEO Sees No Impact from Biosecure Act | MT |
Mar. 27 | AstraZeneca's RSV Disease Drug, Breast Cancer Combination Therapy Receive Approval in Japan | MT |
Official Publications
- Stock
- Equities
- Stock AstraZeneca PLC - London S.E.
- News AstraZeneca PLC
- Official Publications